Beranda › Obesitas › California › Concord
Uji klinis Obesitas di Concord, CA
18 studi untuk Obesitas mencari peserta di lokasi sekitar Concord (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Menerima pesertaFase 2
- John Muir Health - Concord /ID# 282469, Concord
- Diablo Clinical Research /ID# 282530, Walnut Creek · 5 mi jauhnya
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Menerima pesertaFase 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Menerima pesertaFase 2
- Diablo Clinical Research - Flourish Research, Walnut Creek · 5 mi jauhnya
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Menerima pesertaFase 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Menerima pesertaFase 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Menerima pesertaFase 3
- Research Site, Walnut Creek · 5 mi jauhnya
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Menerima pesertaFase 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Menerima pesertaFase 3
- Research Site, Walnut Creek · 5 mi jauhnya
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Menerima pesertaFase 3
- Diablo Clinical Research, Walnut Creek · 5 mi jauhnya
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Menerima pesertaFase 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Menerima pesertaFase 2
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Menerima pesertaFase 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Menerima pesertaFase 2
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Menerima pesertaFase 3
- Diablo Clinical Research, Walnut Creek · 5 mi jauhnya
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Menerima pesertaFase 3
- John Muir Physicians Network, Concord
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Menerima pesertaFase 2
- Diablo Clinical Research - Flourish Research, Walnut Creek · 5 mi jauhnya
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Menerima pesertaFase 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Menerima pesertaFase 1
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Uji klinis Obesitas di kota lain
- Houston, TX43 studi
- Chicago, IL41 studi
- New York City, NY40 studi
- San Antonio, TX40 studi
- Washington, DC33 studi
- Orlando, FL31 studi
- Dallas, TX30 studi
- Boston, MA28 studi
- Las Vegas, NV27 studi
- Miami, FL27 studi
- Baltimore, MD25 studi
- Jacksonville, FL25 studi
Studi lain di Concord
- Kelebihan Berat Badan16 studi
- Kanker Paru Non-Sel Kecil14 studi
- Gangguan Depresi Mayor12 studi
- Diabetes Tipe 210 studi
- Kanker Paru9 studi
- Kanker Payudara9 studi
- Migrain8 studi
- Kanker (semua jenis)7 studi
- Kanker Prostat6 studi
- Depresi6 studi
- Tekanan Darah Tinggi5 studi
- Diabetes5 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.